Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00506779
First received: July 23, 2007
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)